Related Experiment Videos
(Hydroxy)-chloroquine retinal toxicity: two case reports and safety guidelines.
1tineherman@hotmail.com
Bulletin De La Societe Belge D'Ophtalmologie
|August 7, 2002
Summary
Antimalarial drugs like chloroquine and hydroxychloroquine can cause retinal toxicity. Monitoring dosage and regular eye exams are crucial to prevent irreversible retinopathy.
Area of Science:
- Ophthalmology
- Pharmacology
- Rheumatology
Background:
- Antimalarial drugs, including chloroquine and hydroxychloroquine, are widely used for conditions like malaria and autoimmune diseases.
- Retinal toxicity is a known complication of long-term antimalarial therapy, potentially leading to vision impairment.
Observation:
- Retinopathy from antimalarials can manifest as reversible premaculopathy or irreversible retinopathy.
- Risk factors include daily dosage relative to lean body weight, cumulative drug dosage, and specific drug used.
Findings:
- Chloroquine daily dosage should not exceed 4 mg/kg lean body weight; exceeding 300g total dose increases risk.
- Hydroxychloroquine daily dosage should not exceed 6.5 mg/kg lean body weight; risk increases after 8 years of treatment.
Implications:
- Regular dilated fundus examinations and visual field testing (Amsler grid, automated perimetry) are recommended for early detection of premaculopathy.
- Case studies highlight hydroxychloroquine toxicity from excessive cumulative dosage and chloroquine toxicity from excessive daily dosage.